CIK 0001609809 · Non-accelerated filer<br>Smaller reporting company
Seres Therapeutics, Inc.
Sign in to watch- Ticker
- MCRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 274326290
- Phone
- 617 945 9626
- Business address
- 200 SIDNEY STREET, CAMBRIDGE, MA, 02139
- Former names
- Seres Therapeutics, Inc., Seres Health, Inc.
- 8-K Event Executive or director change · Shareholder vote results · Other events
- DEF 14A Proxy Proxy Statement
- 10-K Report Annual Report
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Executive or director change
- 8-K Event Executive or director change
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations · Other events
- 8-K Event Results of operations · Delisting notice · Regulation FD disclosure
- 8-K Event Material agreement · Agreement ended · Acquisition or sale completed · Unregistered share sale · Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · Agreement ended · Unregistered share sale
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 8-K Event Debt accelerated
- 8-K Event Delisting notice
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
Page 2 of 8 · 144 filings